ArticleBMC cancer2021

Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.

Teppei Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.